Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01812499
Other study ID # S55141
Secondary ID
Status Completed
Phase N/A
First received February 12, 2013
Last updated March 13, 2013
Start date January 2013

Study information

Verified date February 2013
Source Universitaire Ziekenhuizen Leuven
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Observational

Clinical Trial Summary

Inhospital the blood transfusion process consists of many phases: ordering the blood product, analysis of the blood sample, delivery, transport and storage of the blood product and administration. In each of these phases (near) accidents may occur. A severe transfusion incident refers to the transfusion of a wrong blood product, whereas a near miss is detected before transfusion.

In 2010 the University Hospitals Leuven introduced a new electronic patient incident report system for transfusion events.

In this study the investigators will analyze the reported blood transfusion events to detect the most common causes of blood transfusion events and the weakest link in the blood transfusion chain.


Description:

A retrospective survey will be conducted of all transfusion events reported in the University Hospitals Leuven between January 2011 and July 2012. Both severe accidents and near misses will be included.

Data will be drawn from the incident report system. Data concerning the number of transfused blood products will be required from the Medical Administration Service.

Events will be classified according to the severity and the cause of the event. The different settings where the events took place will be compared using a chi-square test (p<0,05).


Recruitment information / eligibility

Status Completed
Enrollment 131
Est. completion date
Est. primary completion date February 2013
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- all transfusion events reported in the University Hospitals Leuven between January 2011 and July 2012

- Both severe accidents and near misses were included

Exclusion Criteria:

- Transfusion reactions

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
Belgium University Hospitals Leuven Leuven

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Other Incidence of inhospital blood transfusion events The number of transfusion events divided by the total number of transfused blood products in the study period up to 1,5 years No
Other Is there a relation between misidentification events and the setting where the event took place? The different settings where the events took place will be compared using a chi-square test (p<0,05). up to 1,5 years No
Primary Severity of inhospital blood transfusion events included events will be classified into near misses or severe incidents up to 1,5 years Yes
Secondary Causes of inhospital blood transfusion events Events are classified into human error, technical problems, deficiency of the blood product and others.
Events will also be classified considering the phase in the blood transfusion process.
Causes will be studied hospital wide and per setting were the event took place.
up to 1,5 years No